opens in a new window
Latest News & Media From Quay Pharma
May 16 2022
Bio Integrates 2022
Quay Pharma will be attending Bio Integrates 2022 on 17th May 2022....
Read MoreApril 27 2022
BioTrinity 2022 Conference
Quay Pharma will be sponsoring and attending BioTrinity 26th-27th April 2022....
Read MoreApril 19 2022
Pharmabiotics 2022 Conference & Partnering
Quay Pharma will be attending the 6th Annual Microbiome Connect: Gut Therapeutics 17-18 November, 2021....
Read MoreApril 08 2022
SGS Quay’s Microbiome Expertise Ideal For New IBD Drug Development Project
SGS Quay Pharma is partnering on a major project to develop and commercialise an inflammatory......
Read MoreDecember 10 2021
Acquisition Will Further Strengthen Quay Offering
Quay Pharma has been acquired by SGS, the Swiss-based world leading (TIC) Testing, Inspection and Certification company....
Read MoreNovember 29 2021
Microbiome Connect: Gut Therapeutics Europe
Quay Pharma will be virtually attending the Microbiome Connect: Gut Therapeutics Europe Virtual Event 7-8 December, 2021....
Read MoreNovember 04 2021
6th Annual Microbiome Connect: Gut Therapeutics
Quay Pharma will be attending the 6th Annual Microbiome Connect: Gut Therapeutics 17-18 November, 2021....
Read MoreOctober 21 2021
Microbiome R&D & Business Collaboration Forum: Europe
Quay Pharma will be attending in person the 9th Microbiome R&D & Business Collaboration Forum: Europe 26th - 27th October 2021...
Read MoreMay 07 2021
Quay Pharma Take Part in a Series of Webinars with BioForum Applied Knowledge Center, Israel
For over 20 years Bioforum Applied Knowledge Center has been...
Read MoreApril 29 2021
Quay Pharma Wins Queen’s Award For Industry
Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. ...
Read More
INSPECTED FACILITIES
